Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2002, p. 656-660, Vol. 68, No. 2
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.2.656-660.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Section of Vector Biology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06437,1 Department of Entomology, University of Kentucky, Lexington, Kentucky 40546,2 Insect Molecular Genetics Group, Institute of Molecular Biology and Biotechnology, FORTH-Hellas, Vassilika Vouton, Heraklion 71110, Crete,3 Department of Environmental and Natural Resources Management, University of Ioannina, Agrinio 30100, Greece4
Received 31 July 2001/ Accepted 21 November 2001
|
|
|---|
|
|
|---|
-proteobacteria that infect a diverse range of invertebrate hosts and display the ability to manipulate the reproduction of their hosts via several distinct phenotypes, including cytoplasmic incompatibility, feminization, parthenogenesis, and male killing (14, 25, 31). Although the mechanisms that mediate these reproductive distortions have yet to be defined, the variety of reproductive manipulations induced by Wolbachia species has made this genus a model for the study of reproductive parasitism (3). Additional research has focused on determining the role of Wolbachia in genetic conflict, host reproductive isolation, and speciation (2, 19, 30). The ability of Wolbachia species to affect host reproduction has also made this genus the focus of applied strategies designed to manipulate field populations of medically and economically important invertebrates (23). Since the original description of the genus Wolbachia (11), the inability to culture these symbionts outside of the invertebrate host has continued to be a hindrance to research with these bacteria. With the advent of PCR, molecular techniques have been used to partially circumvent traditional bacteriological methods, permitting the phylogenetic characterization of Wolbachia infections (13, 34, 36) and the recognition of additional infections (33). However, additional research with Wolbachia often requires that a colony of infected host invertebrates be maintained. Not surprisingly, studies of Wolbachia infections that occur in host colonies that are difficult to rear have been limited to a relatively small number of laboratories with appropriate facilities and expertise. As a result, a majority of recent Wolbachia research has been biased toward infections that occur within hosts that are easily reared (e.g., Drosophila). Comparative studies with multiple Wolbachia types have also been limited in part because of the difficult logistics of maintaining multiple host colonies.
Recently, a technique permitting maintenance of Wolbachia in vitro has been developed. This prior research established a cell line from Wolbachia-infected Aedes albopictus embryos (i.e., the Aa23 cell line [15]) and demonstrated that Wolbachia could be stably maintained in vitro using standard cell culture techniques. We hypothesized that the shell vial technique could potentially provide a simplified means of establishing in vitro Wolbachia infections. The shell vial technique, which was originally developed as a diagnostic protocol to detect rickettsial infections, permits the establishment of in vitro rickettsial infections via centrifugation of infected host material onto a monolayer of uninfected cells (24).
Here we report the use of the shell vial technique as a simple means to establish different Wolbachia infections and to examine host cell range. Insect cell lines have been stably infected with two Wolbachia infections from Drosophila simulans (Diptera: Drosophilidae), two infections from a superinfected strain of Cadra cautella (Lepidoptera: Phycitidae), and an infection from Culex pipiens (Diptera: Culicidae). These infections represent a phylogenetically diverse range of Wolbachia types that originate from a broad range of invertebrate hosts. The shell vial technique has been used to establish Wolbachia infections in cell lines derived from A. albopictus (Diptera: Culicidae), Spodoptera frugiperda (Lepidoptera: Noctuidae), and Drosophila melanogaster.
|
|
|---|
Cell culture maintenance.
Wolbachia strain wAlbB-infected (Aa23) and uninfected (Aa23T) A. albopictus cells were maintained as previously described (15). Growth medium consisted of equal volumes of Mitsuhashi-Maramorosch and VP12 media (29) augmented with 10% (vol/vol) heat-inactivated fetal bovine serum (HyClone, Logan, Utah). D. melanogaster Schneider's (S2) cells and S. frugiperda (SF9) cells were grown in Shields and Sang M3 insect medium (Sigma, St. Louis, Mo.) and Grace's insect medium (Sigma), respectively. Cells that were cryogenically stored were frozen by a standard cell culture technique in growth medium augmented with 10% (vol/vol) dimethyl sulfoxide (Sigma). The S2, SF9, and C6/36 tissue culture lines were obtained from the American Type Culture Collection (ATCC; Manassas, Va.).
Wolbachia infections were eliminated from cell culture by adding tetracycline to the growth media at a final concentration of 10 µg/ml. Although tetracycline treatment of a single passage is typically sufficient to eliminate the in vitro Wolbachia infection, residual Wolbachia DNA persists transiently in subsequent passages and can be detected by PCR assay (see Fig. 2). Tetracycline treatment was repeated for three sequential passages.
![]() View larger version (30K): [in a new window] |
FIG. 2. Effect of tetracycline treatment on in vitro wRi Wolbachia infection. The numbers indicate the cell culture passages following the initiation of tetracycline treatment. In this experiment, the ability to detect Wolbachia via PCR amplification was lost prior to the ninth passage. The ability to detect Wolbachia via PCR amplification persisted beyond 30 passages with in vitro infections that had not been treated with tetracycline. A molecular size standard (Std) is shown in the first lane (123 Ladder; Gibco). The arrow indicates 492 bp.
|
PCR amplification and sequencing.
For all PCR amplifications, approximately 106 insect cells were homogenized in 100 µl of STE (0.1 M NaCl, 10 mM Tris-HCl, and 1 mM EDTA [pH 8.0]). Proteinase K (Sigma) was added to a final concentration of 0.4 mg/ml, and this mixture was incubated at 56°C for 1 h. Following heat inactivation at 95°C for 15 min, 1 µl of each of these samples was amplified in a solution containing 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 1.5 mM MgCl2, 0.25 mM deoxynucleoside triphosphates, 0.5 µM primers, and 1 U of Taq DNA polymerase (Life Technologies, Inc., Rockville, Md.) in a total volume of 20 µl. Samples were denatured for 3 min at 94°C and cycled 35 times at 94°C, 55°C, and 72°C (1 min each), using a PTC-200 thermal cycler (MJ Research; Watertown, Mass.); this was followed by a 10-min extension at 72°C. A 10-µl aliquot of each amplification product was electrophoresed on a 1% agarose gel, stained with ethidium bromide, and visualized under UV illumination.
Typically, infection status was monitored using the general wsp primers (primers 81F and 691R [36]). Cultures failing to amplify with the Wolbachia-specific primers were reamplified using 12S mitochondrial primers to verify template quality (13). Diagnostic primers for different Wolbachia types are shown in Table 1. For sequencing, amplified DNA was cleaned using a QiaQuick PCR cleanup kit (Qiagen, Valencia, Calif.) and directly sequenced using an ABI Prism 310 sequencer (Applied Biosystems, Foster City, Calif.).
|
View this table: [in a new window] |
TABLE 1. Characteristics of Wolbachia strains established in vitro
|
|
|
|---|
In addition to examining the robustness of the shell vial technique with a range of invertebrate host taxa, these experiments also demonstrated the ability of the Aa23T cell line to stably maintain a phylogenetically diverse range of Wolbachia infections, including strains from two of the major clades of the genus Wolbachia (i.e., A and B [27]) (Table 1). As an additional test of the shell vial technique, wRi infection was also established in three other uninfected insect cell lines: the dipteran D. melanogaster Schneider's (S2) and A. albopictus C6/36 (ATCC CRL-1660) cell lines and the lepidopteran S. frugiperda (SF9) cell line. All cell lines behaved indistinguishably from the Aa23T cell line in terms of their ability to establish and maintain the wRi Wolbachia infection in vitro.
For all in vitro infections, Wolbachia was initially detected by PCR using diagnostic primers specific for the wsp gene (36) (Table 1). In addition to detection, these primers also permitted an initial verification of the Wolbachia type (Fig. 1). Sequencing of the amplified wsp genes was used to provide additional confirmation of the Wolbachia infection types. In each case, the wsp sequences were identical to previously published sequences derived from in vivo infections (36).
![]() View larger version (28K): [in a new window] |
FIG. 1. Typical results of PCR amplifications of the established in vitro Wolbachia-infected cells (Table 1) and an uninfected (Uninf.) cell line (Aa23T [15]) using Wolbachia-specific (wsp) (Table 1) and general mitochondrial (12S) primers. Amplification with 12S primers was used to verify the quality of the DNA template used in the reactions (13). wCauA and wCauB occur together in a superinfected cell culture (Table 1). A molecular size standard (Std) is shown in the first lane (123 Ladder; Gibco). The arrow indicates 492 bp.
|
![]() View larger version (39K): [in a new window] |
FIG. 3. Anti-WSP immunofluorescence staining of wRi-infected insect cell lines. (A) D. melanogaster Schneider's (S2) cells; (B) S. frugiperda (SF9) cells. Bars, 10 µm.
|
3 months). Cells infected with Wolbachia in vitro can also be frozen and cryogenically stored using standard tissue culture techniques. Stable infections of the wRi infection have been recovered from samples frozen at -70°C for over 6 months. Attempts to maintain Wolbachia in both fresh and spent growth media in the absence of A. albopictus cells were unsuccessful. wRi infection was used to examine the amount of host material required for the successful establishment of in vitro infections. In one set of experiments, egg tissue in amounts ranging from 150 µg to 78 mg was introduced onto Aa23T monolayers. The monolayers were subsequently categorized by infection status. The mean tissue amounts ± standard errors were as follows: uninfected, 7.9 ± 2.9 mg (n = 16); stably infected, 18.5 ± 4.3 mg (n = 16); and contaminated or lost, 29.8 ± 7.1 mg (n = 12). The last two values were determined to be significantly different from the first (P < 0.05; Student's t test). Thus, a positive correlation was observed between the amount of infected donor material overlaid on the cell monolayer and the successful establishment of a stable in vitro infection. At low levels of donor host material, the ability to detect infections was lost in sequential passages of these cultures (i.e., the infection was not stably established). This was expected since the number of recipient host cells in the current protocol remained relatively constant. Therefore, decreasing amounts of Wolbachia-infected donor material should result in a smaller proportion of the recipient host cells becoming infected and an increased opportunity for loss of the infection in subsequent passages of the culture. However, too much host material is also problematic, as this increases the frequency of undesired microbial contamination (i.e., fungal and other contaminants), which can result in the loss of cell cultures. Therefore, in subsequent attempts to establish additional in vitro infections, a protocol was adopted in which the host material was divided into a dilution series which was then introduced onto identical monolayers. The monolayers receiving the highest concentrations of infected host material that were not lost because of microbial contamination were maintained. Unwanted microbial contamination that results in the loss of the cell culture can also be reduced by surface sterilizing eggs and by the use of early embryos as donor host material. Previous research with in vitro infections determined that both penicillin and streptomycin could be added to the growth medium without harming the Wolbachia-infected cells (15). However, these antibiotics were not found to be generally useful for suppressing unwanted bacterial contamination.
Conclusions.
Prior investigations of Wolbachia host cell range have consisted of interspecific transinfection attempts (5, 6, 17, 18, 20, 28). However, interpretation of these prior experiments has been complicated by technical problems associated with embryonic microinjection. Here, we have used a simple technique to demonstrate that six Wolbachia infection types can be supported by A. albopictus cells. We have also shown that the wRi infection may be stably maintained in Drosophila, Spodoptera, and Aedes host cells. Our success in establishing infections suggests that the Wolbachia host cell range is broader than previously thought (17). As an additional test of Wolbachia host cell range, the presently established in vitro infections could be used as a uniform source of different Wolbachia types for future transinfection attempts. For example, different in vitro infections could be microinjected into Drosophila embryos (separately or simultaneously) by previously developed techniques (5, 6, 20) to determine which infections can be stably maintained in vivo and to compare infection dynamics of the different Wolbachia types.
The shell vial technique described here provides a simple means to establish, maintain, and cryogenically store Wolbachia infections. In addition to simplifying and encouraging Wolbachia research in additional laboratories, the expanded use of this technique will allow the generation of a Wolbachia stock center as a scientific resource, permitting the cataloguing and distribution of infections for future reference. The ability to maintain in vitro infections should also permit novel approaches for the examination of Wolbachia. For example, the ability to maintain multiple infection types within a similar host background should simplify future comparative Wolbachia studies, including ultrastructural investigations and the analysis of gene expression patterns, biochemical pathways, and recombination events (32). The in vitro establishment of Wolbachia infections derived from nematodes will facilitate the identification of antimicrobial agents that are useful for eliminating filaria of medical and veterinary importance (10).
This research was supported in part by grants from the United States Department of Agriculture (NRICGP grant 9902683 to S.L.D.), the National Institutes of Health (grant AI40620 to S.L.O.), the McKnight Foundation (to S.L.O.), the UNDP/World Bank/World Health Organization Program for Research and Training in Tropical Diseases (to S.L.O.), and the European Commission (QLK3-CT2000-01079 to K.B.).
Publication 01-08-73 of the University of Kentucky Agricultural Experiment Station. ![]()
Present address: Dept. of Zoology and Entomology, University of Queensland, St. Lucia, QLD 4072, Australia. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»